Nektar Therapeutics
NKTR
#4719
Rank
C$2.82 B
Marketcap
C$100.85
Share price
-0.18%
Change (1 day)
394.03%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): C-$11.15

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$10.90. In 2024 the company made an earnings per share (EPS) of C-$12.12 an increase over its 2023 EPS that were of C-$29.95.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$11.15-7.98%
2024C-$12.12-59.54%
2023C-$29.95-25.89%
2022C-$40.42-31.12%
2021C-$58.6814.86%
2020C-$51.09-1.19%
2019C-$51.70-163.96%
2018C$80.84-725.4%
2017C-$12.93-42.73%
2016C-$22.5783.33%
2015C-$12.3139.53%
2014C-$8.82-69.29%
2013C-$28.72-6.67%
2012C-$30.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$15.23-239.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.86-117.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$19.60-279.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$0.90-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.99-191.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$7.32-167.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
C$0.09575-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
C$2.83-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland